Streamline Scientific Launches Enhanced PCR Reporting Service to Combat Antibiotic Misuse in UTI Treatment
Streamline Scientific's new PCR reporting service integrates clinical guidelines directly into test results to help physicians make more informed antibiotic prescribing decisions for urinary tract infections, addressing the critical issue of antimicrobial resistance.
Streamline Scientific has introduced an enhanced PCR reporting service for urinary tract infection testing that directly incorporates clinical guidelines into laboratory reports, aiming to reduce inappropriate antibiotic prescribing and strengthen stewardship efforts. The service addresses a significant healthcare challenge, as UTIs account for over 10 million doctor visits annually in the U.S., with approximately 30% of antibiotic prescriptions proving to be incorrect choices before lab results are available.
The enhanced reporting service weaves CLSI M100 guidelines, the leading industry standard for microbiology culture and sensitivity testing of UTIs, directly into PCR reports. This integration provides physicians with clearer, more actionable information about detected pathogens and their resistance markers, moving beyond raw data interpretation to directly connect lab results with clinical treatment guidance. According to Shawn Hood, president of Streamline Scientific, "Antibiotic stewardship is one of the most pressing challenges in healthcare today, and UTIs are a major contributor to inappropriate prescribing."
The service offers practical clinical benefits by flagging ineffective drug classes when resistance markers are detected and suggesting better-supported alternatives. For example, when E. coli is identified with sulfonamide or trimethoprim resistance, the report immediately indicates those drug classes as ineffective and recommends more appropriate treatment options. This approach enables faster, more confident prescribing decisions that support both patient recovery and broader antibiotic stewardship initiatives.
For reference laboratories, the service provides a competitive advantage in a crowded market by adding clinical value without requiring new equipment investments. Medical practices benefit from simplified interpretation of complex PCR data, making it easier to align with stewardship goals and strengthen relationships with patients and referring providers. The service builds on existing PCR workflows, allowing for quick implementation without additional hardware or platform investments. More information about the service is available at http://www.streamlinesci.com/reporting.